Dysregulation of cyclins and cyclin-dependent kinases (CDKs) is a hallmark of cancer progression, and inhibition of CDK2 has been shown to suppress XIAP (X-linked inhibitor of apoptosis protein), thereby promoting caspase-mediated apoptosis (31–35). The gene discussed is CDK2; the disease is cancer.